HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Midori Ishikawa Selected Research

2- methyl- 3,5,7,8- tetrahydrothiopyrano(4,3- d)pyrimidine- 4- one

2/2005A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Midori Ishikawa Research Topics

Disease

1Brain Ischemia (Cerebral Ischemia)
02/2005
1Infarction (Infarctions)
02/2005
1Ischemia
02/2005
1Wounds and Injuries (Trauma)
02/2005
1Stroke (Strokes)
02/2005

Drug/Important Bio-Agent (IBA)

1pyrimidineIBA
02/2005
12- methyl- 3,5,7,8- tetrahydrothiopyrano(4,3- d)pyrimidine- 4- oneIBA
02/2005
1Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2005
1EdaravoneIBA
02/2005
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
02/2005
1Poly Adenosine Diphosphate RiboseIBA
02/2005
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2005
1Free Radical ScavengersIBA
02/2005
1Neuroprotective AgentsIBA
02/2005
1Glutamic Acid (Glutamate)FDA Link
02/2005